Online citations, reference lists, and bibliographies.
← Back to Search

New Technologies For Application To Veterinary Therapeutics.

J. Riviere
Published 2010 · Engineering, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
The purpose of this contribution is to review new technologies and make an educated prediction as to how they will impact veterinary pharmacology over the coming decades. By examining past developments, it becomes evident that change is incremental and predictable unless either a transforming discovery or a change in societal behaviour occurs. In the last century, both discoveries and behaviours have dramatically changed medicine, pharmacology and therapeutics. In this chapter, the potential effects of six transforming technologies on veterinary therapeutics are examined: continued advances in computer technology, microfluidics, nanotechnology, high-throughput screening, control and targeted drug delivery and pharmacogenomics. These should lead to the more efficacious and safer use of existing medicants, and the development of novel drugs across most therapeutic classes through increases in our knowledge base, as well as more efficient drug development. Although this growth in technology portends major advances over the next few decades, economic and regulatory constraints must still be overcome for these new drugs or therapeutic approaches to become common practise.
This paper references
Veterinary Pharmacology and Therapeutics
Nicholas H. Booth (1965)
Science and applications
Sigarch (1989)
10.1016/S0022-2836(05)80360-2
Basic local alignment search tool.
S. Altschul (1990)
10.1016/0925-4005(90)80209-I
Miniaturized total chemical analysis systems: A novel concept for chemical sensing
A. Manz (1990)
10.1126/SCIENCE.1990438
Light-directed, spatially addressable parallel chemical synthesis.
S. P. Fodor (1991)
The Human-Animal Bond and Grief
L. Lagoni (1994)
10.1126/science.270.5235.467
Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray
Mark Schena (1995)
10.1073/PNAS.95.1.334
Large-scale temporal gene expression mapping of central nervous system development.
X. Wen (1998)
10.1046/J.1365-2885.1998.00121.X
Population pharmacokinetics in veterinary medicine: potential use for therapeutic drug monitoring and prediction of tissue residues.
T. Martín-Jiménez (1998)
10.1016/S1056-8719(00)00111-8
Genomics and proteomics: the new millennium of drug discovery and development.
M. J. Cunningham (2000)
10.1016/S0169-409X(01)00157-0
Potential and problems of developing transdermal patches for veterinary applications.
J. Riviere (2001)
10.1126/SCIENCE.1063273
Drugs on Target
R. Langer (2001)
10.1053/TVJL.2001.0568
Pharmacological treatment in behavioural medicine: the importance of neurochemistry, molecular biology and mechanistic hypotheses.
K. Overall (2001)
10.1053/TVJL.2001.0579
Pharmacological treatment in behavioural medicine.
S. Mayhew (2001)
10.1016/S0168-3659(01)00331-5
PEG drugs: an overview.
R. B. Greenwald (2001)
10.1126/SCIENCE.1069492
Systems Biology: A Brief Overview
H. Kitano (2002)
10.1046/j.1365-2796.2002.00995.x
Cutaneous gene transfer for skin and systemic diseases
P. Khavari (2002)
10.1046/J.1365-2885.2003.00451.X
A physiologically based pharmacokinetic model for oxytetracycline residues in sheep.
A. Craigmill (2003)
10.1021/AC0346510
Microfluidic devices for the high-throughput chemical analysis of cells.
M. A. McClain (2003)
10.1111/J.1365-2885.2004.00607.X
Therapeutic implications of the MDR-1 gene.
K. Mealey (2004)
10.1023/A:1012129801406
Electrically-Assisted Transdermal Drug Delivery
J. Riviere (2004)
10.1016/J.IJFOODMICRO.2004.02.005
Scientific Criteria to Ensure Safe Food: Institute of Medicine, Natural Research Council of the National Academies. The National Academy Press, Washington D.C.; www.nap.edu; xxi+401 pages; soft cover, $35.95; ISBN 0-309-08928-X (hard cover)
N. Skovgaard (2004)
10.1016/J.TVJL.2003.10.020
Technologies for the control of fat and lean deposition in livestock.
M. Sillence (2004)
Nanotechnology For Dummies
Richard Booker and Earl Boysen (2005)
10.1002/0471478768
Physiologically Based Pharmacokinetic Modeling : Science and Applications
M. Andersen (2005)
10.1039/B403091E
Patterned cell culture inside microfluidic devices.
S. W. Rhee (2005)
10.1128/AAC.01355-05
Use of Probabilistic Modeling within a Physiologically Based Pharmacokinetic Model To Predict Sulfamethazine Residue Withdrawal Times in Edible Tissues in Swine
J. Buur (2006)
10.1007/s11095-006-9217-9
The Evolving Role of Drug Metabolism in Drug Discovery and Development
Lilian G. Yengi (2006)
10.1016/J.VACCINE.2005.09.049
Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system.
G. Widera (2006)
10.1039/B511718F
Microfluidic arrays for logarithmically perfused embryonic stem cell culture.
Lily Y. Kim (2006)
10.2174/138920006777697963
Increasing speed and throughput when using HPLC-MS/MS systems for drug metabolism and pharmacokinetic screening.
Y. Hsieh (2006)
Comprar Nanotoxicology: Characterization, Dosing and Health Effects | Nancy A. Monteiro-Riviere | 9781420045147 | Informa Healthcare
N. A. Monteiro-Riviere (2007)
10.1021/NL070375J
Variables influencing interactions of untargeted quantum dot nanoparticles with skin cells and identification of biochemical modulators.
Jessica P. Ryman-Rasmussen (2007)
10.1016/J.TAAP.2007.03.026
An experimentally based approach for predicting skin permeability of chemicals and drugs using a membrane-coated fiber array.
Xin-Rui Xia (2007)
10.1211/jpp.59.2.0004
Process analytical applications of Raman spectroscopy
J. Rantanen (2007)
10.1111/J.1365-2885.2007.00864.X
Dirlotapide: a review of its properties and role in the management of obesity in dogs.
J. Wren (2007)
10.1126/SCIENCE.316.5831.1553A
Initiative Aims to Merge Animal and Human Health Science to Benefit Both
M. Enserink (2007)
10.3109/9781420045154
Nanotoxicology : characterization, dosing and health effects
N. Monteiro-Riviere (2007)
10.1016/J.TVJL.2007.06.022
The future of veterinary therapeutics: a glimpse towards 2030.
J. Riviere (2007)
10.1038/nnano.2006.180
Towards an in vivo biologically inspired nanofactory.
P. LeDuc (2007)
10.1016/J.JCONREL.2006.11.009
Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin.
F. Verbaan (2007)
Pharmacometrics : the science of quantitative pharmacology
E. Ette (2007)
10.1002/9780470409770
Genomics in Drug Discovery and Development
D. Semizarov (2008)
10.1016/j.yrtph.2008.05.003
Estimating meat withdrawal times in pigs exposed to melamine contaminated feed using a physiologically based pharmacokinetic model.
J. Buur (2008)
10.1021/tx7002118
Quantification of chemical mixture interactions modulating dermal absorption using a multiple membrane fiber array.
R. Baynes (2008)
10.1021/nl803481q
Comparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic model.
H. A. Lee (2009)
10.1002/wnan.24
Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots.
J. Riviere (2009)
The environmental food crisis : the environment's role in averting future food crises
C. Nellemann (2009)
10.1080/10937404.2010.483176
Toxicity Testing in the 21st Century: A Vision and a Strategy
D. Krewski (2010)
10.1002/9780470571224.pse065
Physiologically Based Pharmacokinetic Modeling
H. Clewell (2010)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar